MagForce Nanotechnologies AG Announces Management Team Expansion
MagForce Nanotechnologies AG announced the expansion of its management team. The new positions, Director of Intellectual Property, Director of Business/Corporate Development, Director of Finance & Controlling, and Director of Investor Relations & Corporate Communications, will support both the upcoming product launch of the company's EU approved therapy for the treatment of brain tumors and the further development of its Nano-Cancer® therapy in additional cancer indications. MagForce expects its Nano-Cancer® therapy will become available at several leading German cancer centers in the first quarter of 2011.
Dr. Christoph Rehfuess joins MagForce as Director of Intellectual Property. As a qualified European patent attorney with twelve years of management experience in the biotech intellectual property field at Medigene AG, he will be responsible for patents, trademarks, and technical contracts.
Dr. Dirk Kautz joins MagForce as Director of Business/Corporate Development and will support the Management Board in strategic planning. Prior to joining MagForce, he worked for more than 13 years in the medical devices industry, holding management positions in marketing and corporate development at, among others, Nihon Kohden and Biotronik.
Kajo Wiest joins as Director of Finance & Controlling and brings with him more than 10 years of finance and controlling experience at Jerini AG. During his time at Jerini, he was responsible for the establishment of controlling structures as well as supporting the company's IPO and the sale of its wholly-owned subsidiary JPT, where he served as Finance Manager last year.
Stacy Wiedenmann joins the company as Director of Investor Relations & Corporate Communications and brings with her over 10 years of experience, including her experience at Jerini AG, where she headed the same areas from their IPO through their acquisition.
Dr. Hans Joachim Hutt MD, PhD will support the company in the area of Medical Affairs. His medical training and over 20 years of experience at leading pharmaceutical companies, including Boehringer Ingelheim, Sanofi, Bristol-Myers Squibb, and Sanofi Pasteur MSD, will help MagForce establish commercial networks and expand its therapeutic applications.
Other news from the department people
